Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales.
By D. Cella, D. Eton, J. Lai, A. Peterman, D. Merkel. Journal of Pain and Symptom Management, 2002
799 citations recorded by the source corpus.
Subfields: Hematology, Oncology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/3dba5e5ca65ca9743d37bd1fb4112eabe1566650
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations (2012, background): “, patient global ratings of change, clinical measures) [63] or some combination of the two approaches [64–67].”
- Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. (2003, result): “The magnitude of this change is more than double the 3-point guideline for a minimal CID in this scale.(34) This finding should be interpreted with caution, however, because the analysis of covariance results indicated that some of this change may have been the result of a difference at baseline.”
- Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial (2013, methodology): “Because there are no published data defining a cut point for determining a clinically important change in the score, we defined a 2- to 3-point change as a clinically meaningful improvement in QOL per published recommendations specific to similar measures.(34-37) Using the NCI CTCAE version 3.”
- Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. (2008, neutral): “Median platelet count, 109/L (range) 136 (23-355)”
- Pazopanib versus sunitinib in metastatic renal-cell carcinoma. (2013, neutral): “Increased blood thyrotropin 31 (6) 0 0 66 (12) 0 0”
- Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis (2006, positive): “0 points on the FACT scale represents a clinically meaningful improvement in quality of life from exercise.(42) Additionally, analyses of the physical functioning and physical well-being subscales of quality of life in-”
- Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults (2006, methodology): “They use the empirical distribution of a measure and its psychometric characteristics, such as variability and reliability, to estimate the effect size6,7 or the standard error of measurement (SEM).8,9 Anchor-based methods define a clinical standard for comparison, using the patient’s or provider’s ”
- Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. (2007, methodology): “Cancer-specific QOL and fatigue were assessed by the Functional Assessment of Cancer Therapy–Anemia scale.(10) Psychosocial functioning was assessed by the Rosenberg Self-Esteem Scale,(11) the Center for Epidemiological Studies Depression Scale,(12) and the Spielberger State Anxiety Inventory.”